ABSTRACT
About Cardiac Ablation
Cardiac ablation is an endovascular procedure that helps to treat an irregular heart rhythm and is performed with the help of an ablation device and catheter. These products use radio frequency (RF) as an energy source to destroy unhealthy heart tissues. Ablation catheters remove faulty electrical pathways from the heart, thereby reducing the risk of ventricular fibrillation and sudden cardiac arrest. Cardiac arrhythmias are characterized by an abnormal heart rhythm, which is lower than 60 beats per minute, more than 100 beats per minute, or irregular. The improper functioning of the electrical systems regulating the heart can cause arrhythmia. Arrhythmias are of various types, including atrial fibrillation, atrial flutter, and atrioventricular nodal re-entrant tachycardia.
Technavio’s analysts forecast the global cardiac ablation market to grow at a CAGR of 7.6% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac ablation market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Cardiac Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Boston Scientific
• Medtronic
• St. Jude Medical
Other prominent vendors
• AblaCor
• Advanced Cardiac Therapeutics
• AngioDynamics
• APT Medical
• AtriCure
• BIOTRONIK
• Biosense Webster
• CardioFocus
• DVx
• Galgo Medical
• Hansen Medical
• Imricor
• Lepu Medical
• Melys AFS
• MicroPor Scientific
• Osypka Medical
• PLC Medical Systems
• Spectranetics
• VytronUS
Market driver
• Rising incidences of cardiac diseases and growth of insurance providers.
• For a full, detailed list, view our report
Market challenge
• Complications associated with cardiac ablation and stringent regulatory framework.
• For a full, detailed list, view our report
Market trend
• Transforming marketing and sales strategies for cardiac ablation.
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Global cardiac ablation devices market
• Cardiac ablation catheters market
PART 07: Market segmentation by procedures
• Atrial fibrillation ablation
• Supraventricular tachycardia ablation
• Ventricular tachycardia ablation
PART 08: Market segmentation by end-user
• Hospitals and clinics
• ASCs
PART 09: Geographical segmentation
• Cardiac ablation market in Americas
• Cardiac ablation market in EMEA
• Cardiac ablation market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments
PART 12: Market trends
• Transforming marketing and sales strategies for cardiac ablation
• Emergence of digital cath labs in hospitals
• Integration of robotic cardiac catheter system and hybrid operating room equipment
PART 13: Vendor landscape
• Competitive landscape
PART 14: Key vendor analysis
• Boston Scientific
• Medtronic
• St. Jude Medical
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global cardiac ablation market overview 2016
Exhibit 02: Global cardiac ablation market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global cardiac ablation market by product 2016 and 2021 ($ billions)
Exhibit 05: Buying criteria of cardiac ablation products 2016 and 2021
Exhibit 06: Market overview: Global cardiac ablation devices market
Exhibit 07: Global cardiac ablation devices market 2016-2021 ($ billions)
Exhibit 08: Market overview: Cardiac ablation catheters market
Exhibit 09: Global cardiac ablation catheters market 2016-2021 ($ billions)
Exhibit 10: Global cardiac ablation market by procedures in 2016
Exhibit 11: Global cardiac ablation market by end-user in 2016
Exhibit 12: Global cardiac ablation market by geography 2016 and 2021 ($ billions)
Exhibit 13: An overview of cardiac diseases in US
Exhibit 14: Market overview: Cardiac ablation market in Americas
Exhibit 15: Cardiac ablation market in Americas 2016-2021 ($ billions)
Exhibit 16: Cardiac ablation market in Americas: Market analysis by country
Exhibit 17: Market overview: Cardiac ablation market in US
Exhibit 18: Impact of accountable care organizations (ACO) and ACA on cardiac ablation
Exhibit 19: Market overview: Cardiac ablation market in Europe
Exhibit 20: Cardiac ablation market in EMEA 2016-2021 ($ billions)
Exhibit 21: Cardiac ablation market in EMEA: Market analysis by country
Exhibit 22: Market overview: Cardiac ablation market in UK
Exhibit 23: Market overview: Cardiac ablation market in APAC
Exhibit 24: Cardiac ablation market in APAC 2016-2021 ($ billions)
Exhibit 25: Cardiac ablation market in APAC: Market analysis by country
Exhibit 26: Market overview: Cardiac ablation market in South Korea
Exhibit 27: Increasing number of CVDs (hypertension) versus number of Medicare providers in US 2011-2013
Exhibit 28: Clinical studies for cardiac ablation: Companies and CROs
Exhibit 29: Impact of drivers
Exhibit 30: Cost of cardiac ablation products
Exhibit 31: Research studies: Complications associated with cardiac ablation
Exhibit 32: Product recalls 2014-2015
Exhibit 33: Impact of challenges
Exhibit 34: Marketing and sales strategies by large and small companies
Exhibit 35: Competitive structure analysis of global cardiac ablation market 2016
Exhibit 36: Competitive landscape of global cardiac ablation market 2016
Exhibit 37: Global cardiac ablation market: Market penetration of companies 2016
Exhibit 38: Strategies of large and small companies in global cardiac ablation market
Exhibit 39: Boston Scientific: Strength assessment
Exhibit 40: Boston Scientific: Strategy assessment
Exhibit 41: Boston Scientific: Opportunity assessment
Exhibit 42: Medtronic: Strength assessment
Exhibit 43: Medtronic: Strategy assessment
Exhibit 44: Medtronic: Opportunity assessment
Exhibit 45: St. Jude Medical: Strength assessment
Exhibit 46: St. Jude Medical: Strategy assessment
Exhibit 47: St. Jude Medical: Opportunity assessment
Exhibit 48: Other prominent vendors in global cardiac ablation market
